961 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Momenta's (MNTA) Q4 Loss Wider than Expected, Sales Beat http://www.zacks.com/stock/news/787257/momentas-mnta-q4-loss-wider-than-expected-sales-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-787257 Feb 27, 2020 - Momenta (MNTA) reports mixed Q4 results, with a wider-than-expected loss and revenues beating the same.
Teva Pharmaceutical Gets a Taste of Its Own Medicine As the FDA Approves a Generic of Its Asthma Drug https://www.fool.com/investing/2020/02/24/teva-pharmaceutical-gets-a-taste-of-its-own-medici.aspx?source=iedfolrf0000001 Feb 24, 2020 - A generic approval for Perrigo of Teva's ProAir HFA was highly anticipated.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Bayer Aktiengesellschaft, Pfizer, Mylan N.V. and Teva Pharmaceutical Industries http://www.zacks.com/stock/news/781462/the-zacks-analyst-blog-highlights-johnson-johnson-bayer-aktiengesellschaft-pfizer-mylan-nv-and-teva-pharmaceutical-industries?cid=CS-ZC-FT-press_releases-781462 Feb 24, 2020 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Bayer Aktiengesellschaft, Pfizer, Mylan N.V. and Teva Pharmaceutical Industries
Warren Buffett's 2 Pure-Play Pharma Picks Are Real Head-Scratchers https://www.fool.com/investing/2020/02/24/warren-buffetts-two-pure-play-pharma-picks-are-rea.aspx?source=iedfolrf0000001 Feb 24, 2020 - Berkshire Hathaway's two pure-play pharmaceutical investments are far risker than its other holdings.
Teva gets FDA approval of ArmonAir Digihaler inhalation powder https://seekingalpha.com/news/3544758-teva-gets-fda-approval-of-armonair-digihaler-inhalation-powder?utm_source=feed_news_all&utm_medium=referral Feb 24, 2020 - The U.S. Food and Drug Administration approves Teva's (NYSE:TEVA) ArmonAir Digihaler (fluticasone propionate) Inhalation Powder, and inhaled coriticosteroid delivered via Teva's Digihaler device.Armon
Emergent (EBS) Earnings Miss in Q4, Revenues Beat Estimates http://www.zacks.com/stock/news/777571/emergent-ebs-earnings-miss-in-q4-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-777571 Feb 21, 2020 - Emergent's (EBS) earnings lag estimates in Q4 while revenues surpass the mark.
3 Best Drugmakers That Are Immune to Coronavirus Fright http://www.zacks.com/stock/news/777026/3-best-drugmakers-that-are-immune-to-coronavirus-fright?cid=CS-ZC-FT-analyst_blog|investment_ideas-777026 Feb 21, 2020 - The global reliance on China for APIs and drug manufacturing might hit supply chains and production amid the Coronavirus outbreak. Thus, companies independent of China's input are up for grabs now.
Stocks making the biggest moves in the premarket: ViacomCBS, E-Trade, Zillow, IMAX & more https://www.cnbc.com/2020/02/20/stocks-making-the-biggest-moves-in-the-premarket-viacomcbs-e-trade-zillow-imax-more.html Feb 20, 2020 - The stocks making the biggest moves in premarket trading include ViacomCBS, E-Trade, Zillow, IMAX, and more.
Teva Pharmaceutical's Tourette Syndrome Drug Fails to Meet Endpoints https://www.fool.com/investing/2020/02/19/teva-pharmaceuticals-tourette-syndrome-drug-fails.aspx?source=iedfolrf0000001 Feb 19, 2020 - It's a disappointing setback for a drug that has received previous approvals for similar conditions.
3 Reasons Why Teva Pharmaceutical Is Still A Good Buy https://seekingalpha.com/article/4325291-3-reasons-why-teva-pharmaceutical-is-still-good-buy?source=feed_tag_israel Feb 19, 2020 - Teva exceeded market expectations in the fourth quarter.Prospects continue to improve, driven by strong generic pipeline and two drugs.Fair value on Teva stock modelled.

Pages: 123456...97

Page 1>